described in this review are some conceptual and practical aspects of the methods that can be used to develop b lymphocyte-myeloma hybrids producing such ideal monoclonal antibodies and to isolate renal cells using cell-specific monoclonal antibodies .
C0004561
b lymphocyte
C0026764
myeloma